Highlights
A collection of news and information related to Lipitor (drug) published by this site and its partners.
Displaying items 1-12 of 52
» View wsbtradio.com items only
1
2
3
4
5
•
Next >
-
Study: Car emissions can turn good cholesterol bad
Autoblog.comFiled under: Etc., Safety, Diesel Before you head to the pharmacy to refill your Lipitor prescription, check this out. The American Heart Association's journal on Arteriosclerosis, Thrombosis and Vascular Biology has concluded that high levels of... -
DEALTALK: Warner Chilcott buy may be Actavis' best takeover defense
ReutersBy Jessica Toonkel NEW YORK, May 17 (Reuters) - U.S. generic drugmaker Actavis , the subject of intense takeover speculation, may have found its best defense: a potential purchase of Warner Chilcott Plc, a specialty pharmaceutical company that has been...Tags: Actonel (drug), JPMorgan Chase & Co., Morningstar Incorporated, Patents, Copyrights and Trademarks, Republic of Ireland
-
Shop around for deals on prescription drugs
If your insurance has ever stopped covering a prescription drug or you don’t have coverage at all, you know how quickly costs can mount. Americans spent, on average, $758 out of pocket for medication in 2012, according to a recent Consumer Reports...Tags: CVS Corp., Asthma, Prices, Prescription Drugs, Diabetes
-
RPT-ANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices
Reuters(Repeats to widen readership) By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc...Tags: Merck & Company Incorporated, Private Health Care, Labor Legislation, Emerging Market, Januvia (drug)
-
U.S. spending on medicines fell for first time in 2012
Reuters(Reuters) - Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at least 55 years, according to a report released on Thursday. Overall U.S....Tags: Pfizer Inc., Hospitals and Clinics, Prescription Drugs, Patient Protection and Affordable Care Act, Patents, Copyrights and Trademarks
-
XxANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices
ReutersBy Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc and AstraZeneca have grown...Tags: Merck & Company Incorporated, Private Health Care, Labor Legislation, Emerging Market, Januvia (drug)
-
REFILE-ANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices
Reuters(Removes "XX" from headline) By Deena Beasley LOS ANGELES, May 10 (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer Inc and...Tags: Merck & Company Incorporated, Private Health Care, Labor Legislation, Emerging Market, Januvia (drug)
-
Spending on drugs falls for first time in 55 years
ReutersThe amount of money Americans spend on prescription drugs fell for the first time in 55 years, according to a report from the IMS Institute of Healthcare Informatic. The expiration of patents on widley used drugs such drugs such as Lipitor and Plaviix...Tags: Pfizer Inc., Prescription Drugs, Health Insurance Cost, Patient Protection and Affordable Care Act, Patents, Copyrights and Trademarks
-
Drug spending falls for first time in 6 decades
An explosion of cheap generic substitutes for widely used prescription drugs last year helped drive the first decline in pharmaceutical spending in the U.S. in nearly six decades. Drug makers often lament what they call the patent cliff, which is when...
Tags: Health Insurance, Prescription Drugs, Pharmaceuticals, Patents, Copyrights and Trademarks, Chemical Industry
-
REUTERS SUMMIT-Faster drug approvals a tonic for pharma industry
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) By Ben Hirschler NEW YORK, May 8 (Reuters) - A pickup in new drug approvals, the promise of faster regulatory decisions and more targeted medicines have...Tags: Pfizer Inc., Johnson & Johnson Inc., Diabetes, Patents, Copyrights and Trademarks, Bristol Myers Squibb Company
-
Pfizer's new Viagra strategy
What makes Viagra so interesting? On Monday, my colleague Chad Terhune wrote about Pfizer’s plan to begin selling its little blue pills directly to patients on the company’s website. And within a couple of hours, the story was listed among ...
Tags: Pfizer Inc., Viagra (drug), Prescription Drugs, Drugs and Medicines
-
FDA approves Merck combination cholesterol lowering pill
ReutersMay 3 (Reuters) - The U.S. Food and Drug Administration approved a Merck & Co cholesterol lowering pill that combines a generic version of Pfizer Inc's Lipitor with its own Zetia, Merck said on Friday. The new combination drug will be sold under the brand...Tags: Merck & Company Incorporated, Pfizer Inc., Simvastatin (drug), Zocor (drug), Vytorin (drug)
May 21, 2013
|Blog| Autoblog.com
May 17, 2013
|Story| Reuters
May 12, 2013
|Story| Herald Mail
May 10, 2013
|Story| Reuters
May 8, 2013
|Story| Reuters
May 10, 2013
|Story| Reuters
May 10, 2013
|Story| Reuters
May 9, 2013
|Story| Reuters
May 9, 2013
|Story| Los Angeles Times
May 8, 2013
|Story| Reuters
May 6, 2013
|Story| Los Angeles Times
May 3, 2013
|Story| Reuters
Original site for Lipitor (drug) topic gallery.
